EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Clinical trial NCT03057951 · COMPLETED
Trial details
- NCT number
- NCT03057951
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-02
- Primary completion
- 2021-04-26
- Enrollment
- 5988
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.